Translational Insights for Cretostimogene Grenadenorepvec for BCG-Naïve Bladder Cancer - Trinity Bivalacqua
Trinity Bivalacqua
Trinity Bivalacqua discusses the translational data from CORE-008 Cohort A, examining cretostimogene grenadenorepvec in high-risk BCG-naive NMIBC with a focus on the five-step versus two-step administration protocol.
Feasibility of Using an RNA-Seq Biomarker to Assign Therapy in the OPTIC RCC Trial - Pedro Barata
Pedro Barata
Pedro Barata discusses the OPTIC RCC trial, which uses RNA-sequencing biomarkers to guide treatment selection in metastatic clear cell renal cell carcinoma.
